The Motley Fool
21 Mar 2026, 21:38 UTC · 32w ago
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing
Verdict
Headline takes no side. We score IBB −0.20 across three claims — slightly bearish.
- Expected · IBB
−0.20slightly bearish
−1 bearish0bullish +1More negative than 70% of ticker scores this week
- Actual





